The incidence of biallelic pathogenic mutations in PALB2 and RAD51 paralog C (RAD51C) is observed to be significantly higher in HRD, and the inactivation of these two genes have been demonstrated in previous studies as the major genetic basis of human HRD29–31. This evidence concerns the gene RAD51C and hypoparathyroidism-retardation-dysmorphism syndrome.